N-923
Norfluoxetine oxalate solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Recommended Products
grade
certified reference material
Quality Level
form
liquid
feature
Snap-N-Spike®/Snap-N-Shoot®
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
1.0 mg/mL in methanol (as free base)
technique(s)
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
storage temp.
2-8°C
SMILES string
NCCC(C1=CC=CC=C1)OC2=CC=C(C(F)(F)F)C=C2.OC(C(O)=O)=O
InChI
1S/C16H16F3NO.C2H2O4/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12;3-1(4)2(5)6/h1-9,15H,10-11,20H2;(H,3,4)(H,5,6)
InChI key
FDWJCEPFCGIDPF-UHFFFAOYSA-N
General description
Application
- Forensic Detection of Cocaine and Antidepressants: Norfluoxetine is utilized in the development of an innovative analytical method using magnetic nanoparticles for the forensic detection of cocaine, antidepressants, and their metabolites in postmortem blood samples. This method represents a significant advance in forensic toxicology, providing rapid, sensitive, and reliable results essential for criminal investigations and legal proceedings (de Souza Schwarz et al., 2024).
- Ion Channel Research in Dermatology: Research involving Norfluoxetine investigates its effects on selected ion channels, highlighting its potential implications in skin physiology. This study explores the multifaceted roles of serotonin reuptake inhibitors like Norfluoxetine in dermatological applications, contributing to better understanding and treatment of skin-related disorders (Kim et al., 2023).
- Therapeutic Drug Monitoring: Norfluoxetine is featured in the simultaneous determination of serotonin selective reuptake inhibitors using an advanced UPLC MS-MS method. This method is used in clinical settings for therapeutic drug monitoring, ensuring proper dosage and optimizing treatment outcomes for patients undergoing antidepressant therapy (Eloisa Chávez-Castillo et al., 2022).
- Pharmacological Research on TREK and TRESK Channels: Studies involving Norfluoxetine examine its interaction with TREK and TRESK K2P channels, important for understanding the pharmacological properties of drugs affecting the central nervous system. Such research aids in the development of new therapeutic agents for neurological conditions (Walsh et al., 2021).
- Placental Aromatase Influence by SSRIs: Norfluoxetine is investigated for its impact on placental aromatase, a crucial enzyme in steroid hormone biosynthesis. Understanding how SSRIs affect this enzyme can improve safety profiles and therapeutic strategies during pregnancy, especially concerning fetal development (Hudon Thibeault et al., 2019).
Legal Information
related product
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
Target Organs
Eyes,Central nervous system
WGK
WGK 1
Flash Point(F)
closed cup
Flash Point(C)
closed cup
Regulatory Information
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service